Chronic liver disease is a disease process of the liver that involves a process of progressive destruction and regeneration of the liver tissue leading to fibrosis and cirrhosis. "Chronic liver disease" refers to disease of the liver which lasts over a period of six months. This presentation will focus on the prognostic utility of the Enhanced Liver Fibrosis (ELF) Score in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis due to non-alcoholic steatohepatitis to assess the likelihood of progression to cirrhosis and liver-related clinical events will also be discussed.
Learning objectives
By the end of this session participants will be able to:
- Describe the four main causes of chronic liver disease
- Describe the major risk factors for the development of chronic liver disease
- Explain the clinical and laboratory findings associated with chronic liver disease
- Explain the testing options that can assist in the differential diagnosis of chronic liver disease
Speaker
Jim Aguanno, PhD
Dr. Aguanno received a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri.
Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years.
Dr. Aguanno joined Siemens Healthcare Diagnostics in January of 2004 and is currently Senior Clinical Consultant in the Medical and Scientific Affairs group and provides educational presentations on a variety of clinical topics.
